Combined Antihypertensive and Hypolipidemic Therapy for Arterial Hypertension Hemodynamic Changes and Lipid Spectrum

Abstract

Recently, there has been an increase in cardiovascular diseases, which are the main cause of death worldwide. Arterial hypertension (AH) is the main risk factor for cardiovascular diseases. The high incidence of a combination of hypertension and dyslipidemia in the population is of particular concern. In patients with hypertension, there is a doubling, and with a combination of hypertension and dyslipidemia, a tripling of the risk of death from cardiovascular diseases. Recently, the most interesting is the study of the combined effect of antihypertensive and lipid-lowering therapy on the incidence of cardiovascular complications in patients with hypertension. In this way, the goals of antihypertensive therapy at the present stage are to increase the life expectancy of patients by reducing the risk of developing complications of hypertension and improving the quality of life of patients with a decrease in clinical symptoms and minimizing the risk of developing side effects of therapy. The correct choice of tactics for the treatment of patients with allows you to maintain your ability to work, significantly prolong the life of the patient and improve his quality of life [1, 2, 4, and 5].